Danma Biotech completed the A-round financing of nearly 20 million U.S. dollars
Danma Bio is an innovative drug developer. Danma Bio has established its own GAMID® (Genetics-centric And Multi-omics Integrated Data) target discovery platform, based on massive human disease genome-wide association study (GWAS) data , and integrate the growing multi-omics data such as proteome GWAS and transcriptome GWAS, large-scale and systematic application of Mendelian randomization (Mendelian Randomization) […]
Danma Biotech completed the A-round financing of nearly 20 million U.S. dollars Read More »